IP-6

IP-6

Evidence status

Limited evidence to recommend for any consumer outcome yet.

2 papers · 0 claims · 7 outcomes scored

Risk profile

Adverse events and known drug interactions

Safety events

hypoglycemia severe

Drug interactions

Cyclophosphamide moderate decreases concentration

Sources

1. Daily phytate intake increases adiponectin levels among patients with diabetes type 2: a randomized crossover trial. (2023) ↑
2. Phytate Decreases Formation of Advanced Glycation End-Products in Patients with Type II Diabetes: Randomized Crossover Trial. (2018) ↑

Generated August 14, 2026

Related

More evidence for IP-6

Evidence map
Metabolic health
Metabolic health: evidence map across 82 supplements
Evidence coverage map
Jul 30, 2026